OPKO Health, Inc. (OPK)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, OPKO Health, Inc. currently loses $5.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 55 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About OPKO Health, Inc.
OPKO Health, Inc. (NASDAQ: OPK) is a healthcare company focused on diagnostics and drug products. In FY2025, it recorded $606.9 million in revenue. Its business spans laboratory testing, point-of-care diagnostic systems, and branded and generic pharmaceutical offerings through diagnostics and pharmaceutical operations.
Today's Snapshot
OPK closed 3.1% below yesterday's close, while its sector was flat. Shares changed hands at about two-fifths of its usual level.
Trading Volume
Below 10d avg (3.4M)
1.4M
vs S&P 500 Today
Underperforming Market
-2.72%
Updated: September 9, 2026 at 20:22 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$1.35 - $1.55Buy
- RSI (14)55.46Neutral
- Stochastic %K (14, 3, 3)58.85Neutral
- MACD Level (12, 26)0.06Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.